Beatriz Luiza Pinheiro Alves Azevedo

Beatriz Luiza Pinheiro Alves Azevedo

Auto-generated profile, based on publicly available information

Beatriz Luiza Pinheiro Alves Azevedo

Faculty of Physiotherapy, Centro Universitário Augusto Motta (UNISUAM), Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2023 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
JOJéssica Gabriela Messias Oliveira
Jéssica Gabriela Messias Oliveira
RCRenan Pereira Campos
Renan Pereira Campos
BABeatriz Luiza Pinheiro Alves Azevedo
Beatriz Luiza Pinheiro Alves Azevedo
SASamantha Gomes Alegria
Samantha Gomes Alegria
PLPatrícia Frascari Litrento
Patrícia Frascari Litrento
Agnaldo José LopesAgnaldo José Lopes
Agnaldo José Lopes
Objective: To investigated the dynamic ventilatory responses and their influence on functional exercise capacity in patients with long-COVID-19 syndrome (LCS). Results: Sixteen LCS patients were subjected to resting lung function (spirometry and respiratory oscillometry-RO) and cardiopulmonary performance to exercise (Spiropalm®-equipped six-minute walk test-6MWT and cardiopulmonary exercise test-CPX). At rest, spirometry showed a normal, restrictive and obstructive pattern in 87.5%, 6.25% and 6.25% of participants, respectively. At rest, RO showed increased resonance frequency, increased integrated low-frequency reactance and increased difference between resistance at 4–20 Hz (R4-R20) in 43.7%, 50%, and 31.2% of participants, respectively. The median of six-minute walking distance (DTC6) was 434 (386–478) m, which corresponds to a value of 83% (78–97%) of predicted. Dynamic hyperinflation (DH) and reduced breathing reserve (BR) were detected in 62.5% and 12.5% of participants, respectively. At CPX, the median peak oxygen uptake (VO2peak) was 19 (14–37) ml/kg/min. There was a significant correlation of 6MWD with both R4-R20 (rs=-0.499, P = 0.039) and VO2peak (rs=0.628, P = 0.009). Our results indicate that DH and low BR are contributors to poor exercise performance, which is associated with peripheral airway disease. These are promising results considering that they were achieved with simple, portable ventilatory and metabolic systems.

6 April 2023 in Physiotherapy Research International
Verified
Journal Article
Closed access
RDRafael Alexandre de Oliveira Deucher
Rafael Alexandre de Oliveira Deucher
LRLuis Felipe Fonseca Reis
Luis Felipe Fonseca Reis
JPJannis Vasileios Papathanasiou
Jannis Vasileios Papathanasiou
BABeatriz Luiza Pinheiro Alves Azevedo
Beatriz Luiza Pinheiro Alves Azevedo
JOJéssica Gabriela Messias Oliveira
Jéssica Gabriela Messias Oliveira
Agnaldo José LopesAgnaldo José Lopes
Agnaldo José Lopes

28 July 2025 in Journal of Scleroderma and Related Disorders
Verified
Journal Article
Closed access
SASamantha Gomes Alegria
Samantha Gomes Alegria
MSMATHEUS MELLO DA SILVA
MATHEUS MELLO DA SILVA
BABeatriz Luiza Pinheiro Alves Azevedo
Beatriz Luiza Pinheiro Alves Azevedo
JOJéssica Gabriela Messias Oliveira
Jéssica Gabriela Messias Oliveira
IFIaamim Maria Pereira Pinto Fonseca
Iaamim Maria Pereira Pinto Fonseca
Agnaldo José LopesAgnaldo José Lopes
Agnaldo José Lopes
Objective: There is still a wide variation in the rehabilitation programs developed for systemic sclerosis, which makes it urgent to develop feasible and easy-to-use protocols using tools capable of measuring the response to rehabilitation. The Glittre-ADL test assesses functional exercise capacity using activities of daily living and is useful due to the hands involvement. This study aimed to evaluate the effects of a physiotherapist-supervised home-based rehabilitation program on functional exercise capacity in women with systemic sclerosis using the Glittre-ADL test. A secondary aim was to evaluate the association between the Glittre-ADL test and handgrip strength, hand function, physical function, quality of life, and lung function. Methods: This is a quasi-experimental study in which 33 women with systemic sclerosis underwent a physiotherapist-supervised home-based rehabilitation program for 12 weeks. The following pre- and post-physiotherapist-supervised home-based rehabilitation program assessments were performed: Glittre-ADL test, Health Assessment Questionnaire Disability Index, Cochin Hand Functional Scale, Short Form 36 Health Survey, handgrip strength, and spirometry. Results: There was a significant increase in Glittre-ADL test time after physiotherapist-supervised home-based rehabilitation program ( p = 0.036). There was a significant decrease in manual time of the Glittre-ADL test between pre- and post-physiotherapist-supervised home-based rehabilitation program ( p = 0.001). For Health Assessment Questionnaire Disability Index, there was a significant decrease from 1.13 (0.5–1.8) points before physiotherapist-supervised home-based rehabilitation program to 1.0 (0.4–1.3) points after physiotherapist-supervised home-based rehabilitation program ( p = 0.004). For the Cochin Hand Functional Scale, there was a decrease from 14 (5–35) points before physiotherapist-supervised home-based rehabilitation program to 7 (3–21) points after physiotherapist-supervised home-based rehabilitation program ( p = 0.0002). There was a significant increase in handgrip strength between pre- and post-PHPR ( p = 0.008). The delta for Glittre-ADL test time (%predicted) was significantly correlated with the delta for handgrip strength ( r s = −0.360, p = 0.039). Conclusion: After physiotherapist-supervised home-based rehabilitation program, women with systemic sclerosis require less time to complete the Glittre-ADL test tasks. Physiotherapist-supervised home-based rehabilitation program improves manual function, physical function, handgrip strength, lung function, and quality of life. There is a relationship between Glittre-ADL test time and handgrip strength. These results suggest that a 12-week physiotherapist-supervised home-based rehabilitation program could be a beneficial non-pharmacological therapy that reduces functional limitations and improves quality of life in systemic sclerosis.